Dermatology Growth, Engineered
Precision strategy and execution for biologic brands in atopic dermatitis, psoriasis, and immunology.
Unlocking the next $100M–$1B within your portfolio
HoneyKey Consulting is a boutique advisory firm focused exclusively on dermatology and immunology.
We partner with commercial leaders to identify and activate the highest-value growth opportunities within biologic portfolios transforming strategy into measurable revenue.
Commercial Acceleration
- Strategic growth across AD, psoriasis, and emerging indications.
Revenue Expansion
- Activation of under-penetrated prescribers, segments, and channels.
Execution Infrastructure
- Alignment across marketing, sales, and access to deliver performance at scale.
Our Services
Dermatology. Focused
We operate exclusively within dermatology — where complexity, competition, and opportunity intersect.
- Atopic Dermatitis (AD) – High-growth biologic landscape driven by evolving treatment pathways
- Psoriasis (PsO) – Highly competitive IL-17 and IL-23 market requiring precision positioning
- Biologic Therapies – Deep expertise across Dupixent, Bimzelx, and next-generation immunology assets
- Emerging Indications – HS, vitiligo, and pipeline expansion strategy
Where Most Strategy Stops, We Begin
Most consulting firms deliver strategy.Few translate it into revenue.
HoneyKey is built to close that gap.
- Dermatology-only specialization — no dilution
- Designed for biologic complexity and market access realities
- Deep understanding of dermatologist and APP prescribing behavior
- Cross-functional alignment across marketing, sales, and access
- Execution embedded at the field level
We don’t advise growth. We operationalize it.
Measured in Revenue
Our work is designed to deliver measurable financial impact — not theoretical lift.
Incremental Growth Potential
- +10% → Significant revenue acceleration
- +20% → Market leadership expansion
- +30% → Category-defining performance
Multi-year impact across 2026–2030 creates exponential portfolio value.
Our Approach
Activate at the prescriber level with precision and accountability
3-Step Model
- Identify – Pinpoint the highest-value growth levers across the portfolio
- Align – Integrate strategy across commercial, medical, and access functions
- Execute – Activate at the prescriber level with precision and accountability
Who We Work With
We partner with a select group of leaders shaping the future of dermatology.
Targets
- Franchise Heads (Dermatology / Immunology)
- Brand Leaders (Biologics)
- Commercial & Sales Executives
- Market Access Leadership
- Biotech and Private Equity-backed assets
Engagements are limited to ensure focus and impact.
Engagement Model
HoneyKey operates through high-impact, fixed-term engagements.
Structure
- 6–12 month strategic engagements
- Defined revenue targets and milestones
- Optional performance-based incentives tied to growth
Aligned to value. Structured for impact.
